On the contrary, in another study, patients positive for HHLA2 had a lower mortality rate than patients negative for HHLA2 after 56 months (12.7% and 37.5%, respectively), suggesting HHLA2 expression to be a sign of good prognosis in HCC. This evidence concerns the gene HHLA2 and hepatocellular carcinoma.